The Mutation of CD27 Deficiency Presented With Familial Hodgkin Lymphoma and a Review of the Literature

Doğan Köse1, Ahmet Güzelçiçek2, Özlem Öz3

  • 1Departments of Pediatric Hematology and Oncology.

Insights

This study links CD27 deficiency to Hodgkin lymphoma risk in siblings. Homozygous CD27 variants were found in affected children, suggesting a genetic link, but environmental factors may also play a role.

Area of Science:

  • Immunology
  • Genetics
  • Oncology

Background:

  • CD27 is a crucial protein in the immune system, involved in lymphocyte activation and differentiation.
  • Hodgkin lymphoma is a cancer of the lymphatic system with complex etiology.
  • Genetic predispositions are increasingly recognized in various cancers, including lymphomas.

Observation:

  • A family with a high incidence of Hodgkin lymphoma was investigated for CD27 mutations.
  • Exome sequencing identified a shared heterozygous CD27 variant in the parents and a homozygous variant in affected siblings.
  • The study observed that CD27 deficiency might influence regulatory T cell (Treg) differentiation.

Findings:

  • Four siblings with Hodgkin lymphoma were homozygous for a specific CD27 variant.
  • Other homozygous siblings without lymphoma suggest additional contributing factors.
  • The genetic analysis confirmed a strong association between CD27 deficiency and Hodgkin lymphoma susceptibility.

Implications:

  • This research strengthens the evidence for CD27 mutations as a significant factor in Hodgkin lymphoma etiology.
  • The findings highlight the potential role of genetic screening for CD27 deficiency in at-risk families.
  • Environmental factors likely interact with genetic predisposition in the development of Hodgkin lymphoma.

Related Concept Videos